These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 4026882)

  • 1. Evidence that (+)[3H]amphetamine binds to acceptor sites which are not MAO-A.
    Lesage A; Strolin Benedetti M; Rumigny JF
    Biochem Pharmacol; 1985 Aug; 34(16):3000-2. PubMed ID: 4026882
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of the hepatic metabolism of amphetamine by desipramine.
    Dingell JV; Bass AD
    Biochem Pharmacol; 1969 Jun; 18(6):1535-8. PubMed ID: 5799123
    [No Abstract]   [Full Text] [Related]  

  • 3. Paradoxical amphetamine effect in hyperactive rats in relation to norepinephrine metabolism.
    Ladisich W; Volbehr H; Matussek N
    Neuropharmacology; 1970 Jul; 9(4):303-10. PubMed ID: 5466110
    [No Abstract]   [Full Text] [Related]  

  • 4. Localization in rat brain of binding sites for parkinsonian toxin MPTP: similarities with [3H]pargyline binding to monoamine oxidase.
    Rainbow TC; Parsons B; Wieczorek CM; Manaker S
    Brain Res; 1985 Mar; 330(2):337-42. PubMed ID: 3872699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of imidazoline-receptor binding sites in cortex and medulla of the bovine adrenal gland. Colocalization with MAO-A and MAO-B.
    King PR; Gundlach AL; Louis WJ
    Ann N Y Acad Sci; 1999 Jun; 881():161-70. PubMed ID: 10415911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intestinal metabolism of tyramine by both forms of monoamine oxidase in the rat.
    Benedetti MS; Boucher T; Carlsson A; Fowler CJ
    Biochem Pharmacol; 1983 Jan; 32(1):47-52. PubMed ID: 6830619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amphetamine-tetrazolium reductase activity in brain.
    Guha SR; Mitra C
    Biochem Pharmacol; 1971 Dec; 20(12):3539-42. PubMed ID: 4399896
    [No Abstract]   [Full Text] [Related]  

  • 8. 4-Fluoro-3-nitrophenyl azide, a selective photoaffinity label for type B monoamine oxidase.
    Chen S; Shih JC; Xu QP
    Biochem Pharmacol; 1985 Mar; 34(6):781-8. PubMed ID: 3977955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) binding sites in C57BL/6 mouse brain: mutual effects of monoamine oxidase inhibitors and sigma ligands on MPTP and sigma binding sites.
    Itzhak Y; Mash D; Zhang SH; Stein I
    Mol Pharmacol; 1991 Mar; 39(3):385-93. PubMed ID: 1848660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [3H]8-OH-DPAT binding and serotonin content in rat cerebral cortex after acute fluoxetine, desipramine, or pargyline.
    Carli M; Afkhami-Dastjerdian S; Reader TA
    J Psychiatry Neurosci; 1996 Mar; 21(2):114-22. PubMed ID: 8820177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of stereoisomers of 2- and 9- aminobenzonorbornenes on food intake, brain serotonin concentration and monoamine oxidase activity in the rat.
    Gray NM; Lu MC; Bhargava HN
    J Pharmacol Exp Ther; 1982 Apr; 221(1):58-62. PubMed ID: 7062292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disposition and behavioral effects of amphetamine and , -difluoroamphetamine in mice.
    Fuller RW; Molloy BB; Roush BW; Hauser KM
    Biochem Pharmacol; 1972 May; 21(9):1299-307. PubMed ID: 5038675
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition of monoamine oxidase activity by antidepressants and mood stabilizers.
    Fisar Z; Hroudová J; Raboch J
    Neuro Endocrinol Lett; 2010; 31(5):645-56. PubMed ID: 21200377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methadone, monoamine oxidase, and depression: opioid distribution and acute effects on enzyme activity.
    Kaufmann CA; Kreek MJ; Raghunath J; Arns P
    Biol Psychiatry; 1983 Sep; 18(9):1007-21. PubMed ID: 6685534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction between cytosolic monoamine oxidase and spin-labeled amphetamine and its modification by clorgyline and pargyline.
    Copeland ES; Campbell IC; Murphy DL
    Biochim Biophys Acta; 1983 Feb; 743(1):186-94. PubMed ID: 6824699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo effect of BU99006 (5-isothiocyanato-2-benzofuranyl-2-imidazoline) on I2 binding in relation to MAO: evidence for two distinct I2 binding sites.
    Paterson LM; Tyacke RJ; Robinson ES; Nutt DJ; Hudson AL
    Neuropharmacology; 2007 Feb; 52(2):395-404. PubMed ID: 17045310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Biotransformation of amphetamine derivatives by rat liver mitochondria/2nd communication; Oxidative deamination of amphetamine and reduction of phenylacetone].
    Blume H
    Arzneimittelforschung; 1981; 31(6):994-7. PubMed ID: 7196246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correspondence between 3H-MPP+ binding site and MAO-A enzyme: pharmacological evidences.
    Ruiu S; Piccardi MP; Corsini GU; Del Zompo M
    Pharmacol Res; 1989; 21 Suppl 1():15-6. PubMed ID: 2633172
    [No Abstract]   [Full Text] [Related]  

  • 19. [Amphetamine action on morphochemical brain organization].
    Dovedova EL
    Zh Nevrol Psikhiatr Im S S Korsakova; 2003; 103(12):39-41. PubMed ID: 14763255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between I2 imidazoline binding sites and monoamine oxidase B in liver.
    Remaury A; Ordener C; Shih J; Parini A
    Ann N Y Acad Sci; 1999 Jun; 881():32-4. PubMed ID: 10415894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.